An expert panel convened by the American Lung Association and the Pulmonary Hypertension Association has developed practical flowcharts…
Articles by Andrea Lobo
A part of NOTCH3, a protein involved in disease-related alterations in blood vessels, may be a biomarker of idiopathic…
Yutrepia, an inhaled dry powder formulation of treprostinil that won regulatory approval in the U.S. in May 2025, was…
Early diagnosis of pulmonary arterial hypertension (PAH), less than six months after symptom onset, improves five-year survival by 42% compared…
Pulmonary hypertension (PH) in extremely premature infants — those born…
The U.S. Food and Drug Administration (FDA) has cleared Cereno Scientific’s request to launch a global Phase 2b trial…
People with chronic thromboembolic pulmonary hypertension (CTEPH) who have a high pulmonary arterial wedge pressure (PAWP)…
Two proteins associated with the aggregation and activation of platelets may serve as biomarkers of chronic thromboembolic pulmonary hypertension (CTEPH)…
Treprostinil may help manage pulmonary hypertension (PH) in children who’ve undergone Fontan surgery for congenital heart defects, according to…
For pregnant women with pulmonary hypertension (PH), higher pulmonary arterial pressure — blood pressure levels in the blood vessels…
Pulmonary endarterectomy (PEA), a surgery to remove blood clots in individuals with chronic thromboembolic pulmonary hypertension (CTEPH), may be…
Treatment with a combination of sildenafil and statins improved exercise capacity and reduced pulmonary arterial pressure in people with…